Citation Formats
Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. ERDAL Et Al. , "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle," International Journal of Pharmaceutics , vol.645, 2023

ERDAL, E. Et Al. 2023. Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle. International Journal of Pharmaceutics , vol.645 .

ERDAL, E., BAKICI, C., Arslan, A., BATUR, B., YAMAN, M. E., Alçığır, M. E., ... AKYOL, M.(2023). Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle. International Journal of Pharmaceutics , vol.645.

ERDAL, EBRU Et Al. "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle," International Journal of Pharmaceutics , vol.645, 2023

ERDAL, EBRU Et Al. "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle." International Journal of Pharmaceutics , vol.645, 2023

ERDAL, E. Et Al. (2023) . "Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle." International Journal of Pharmaceutics , vol.645.

@article{article, author={EBRU ERDAL Et Al. }, title={Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle}, journal={International Journal of Pharmaceutics}, year=2023}